Latigo Biotherapeutics, Inc. Common Stock (LTGO) — Net Asset Quality Index
Latigo Biotherapeutics, Inc. Common Stock (LTGO) has a Net Asset Quality Index of -499.4% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $50.58 Million minus total liabilities of $303.16 Million yields net assets of $-252.58 Million. A higher index indicates a stronger, lower-leverage balance sheet. For live market cap and overall valuation, see how much is Latigo Biotherapeutics, Inc. Common Stoc worth.
Quality Index
Net Assets
Total Assets
Total Liabilities
Latigo Biotherapeutics, Inc. Common Stock Net Asset Quality Index Over Time (2024–2025)
This chart shows how Latigo Biotherapeutics, Inc. Common Stock's Net Asset Quality Index has evolved across 2 annual periods from 2024 to 2025. As of March 2026, the index stands at -499.4%, representing net assets of $-252.58 Million against total assets of $50.58 Million USD. See LTGO net asset value for net asset value and shareholders' equity analysis.
Annual Net Asset Quality Index for Latigo Biotherapeutics, Inc. Common Stock (2024–2025)
The table below presents the year-by-year Net Asset Quality Index for Latigo Biotherapeutics, Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Also explore LTGO net asset momentum to track the company's year-over-year net asset growth rate.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -306.8% | $-231.67 Million | $75.52 Million | $307.19 Million | ▲ +260.0 pp |
| 2024 | -566.8% | $-129.60 Million | $22.86 Million | $152.46 Million | — |